Linked Life Data

8401372

Source:http://linkedlifedata.com/resource/pubmed/id/8401372

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8401372rdf:typepubmed:Citationlld:pubmed
pubmed-article:8401372lifeskim:mentionsumls-concept:C0025663lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0242209lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0303611lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C1709915lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C1548779lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C1947902lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C2827499lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C0077505lld:lifeskim
pubmed-article:8401372lifeskim:mentionsumls-concept:C1167624lld:lifeskim
pubmed-article:8401372pubmed:issue6lld:pubmed
pubmed-article:8401372pubmed:dateCreated1993-11-16lld:pubmed
pubmed-article:8401372pubmed:abstractTextWe have developed a very efficient labeling technique for monoclonal antibodies with technetium-99m. Oxidation of sugar residues on the IgG class of antibodies leads to the generation of aldehyde groups which are further reacted with two newly developed hydrazide compounds. This methodology introduces sulfhydryl groups on the antibody through sugar residues which can be labeled with technetium-99m. We have studied the TAG-72 specific second generation antibody CC-49. The specific activity of the labeled antibody was high without loss of its immunoreactivity.lld:pubmed
pubmed-article:8401372pubmed:languageenglld:pubmed
pubmed-article:8401372pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:citationSubsetIMlld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8401372pubmed:statusMEDLINElld:pubmed
pubmed-article:8401372pubmed:monthAuglld:pubmed
pubmed-article:8401372pubmed:issn0969-8051lld:pubmed
pubmed-article:8401372pubmed:authorpubmed-author:BloomerW DWDlld:pubmed
pubmed-article:8401372pubmed:authorpubmed-author:EpperlyM WMWlld:pubmed
pubmed-article:8401372pubmed:authorpubmed-author:RanadiveG NGNlld:pubmed
pubmed-article:8401372pubmed:authorpubmed-author:RosenzweigH...lld:pubmed
pubmed-article:8401372pubmed:authorpubmed-author:SeskeyTTlld:pubmed
pubmed-article:8401372pubmed:issnTypePrintlld:pubmed
pubmed-article:8401372pubmed:volume20lld:pubmed
pubmed-article:8401372pubmed:ownerNLMlld:pubmed
pubmed-article:8401372pubmed:authorsCompleteYlld:pubmed
pubmed-article:8401372pubmed:pagination719-26lld:pubmed
pubmed-article:8401372pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:meshHeadingpubmed-meshheading:8401372-...lld:pubmed
pubmed-article:8401372pubmed:year1993lld:pubmed
pubmed-article:8401372pubmed:articleTitleA new method of technetium-99m labeling of monoclonal antibodies through sugar residues. A study with TAG-72 specific CC-49 antibody.lld:pubmed
pubmed-article:8401372pubmed:affiliationDepartment of Radiation Oncology, University of Pittsburgh, PA 15213.lld:pubmed
pubmed-article:8401372pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8401372pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:8401372pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed